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CSFs are essential for hemopoietic progenitor cells to proliferate and differ-
entiate in vitro as well as in vivo . Recently, granulocyte/macrophage colony-
stimulating factor (GM-CSF),' granulocyte-CSF (G-CSF), macrophage-CSF, IL-
3, and IL-4 (B cell stimulatory factor 1) have been highly purified and character-
ized and their gene structures have been determined (1-6) .
A B cell-active factor, T cell-replacing factor (TRF) derived from the B151
T cell hybridoma (7), has been shown to promote IgM secretion by the BCL I B
cell line and to induce hapten-specific IgG secretion in vitro by in vivo antigen-
primed B cells (7-9) . More recently, purified TRF has been shown (9) to have B
cell growth factor 11 (BCGF-I1) activity, as well as B cell differentiation factor
(BCDF) activity . BCGF-II activity was originally described by Swain and Dutton
(10) as the ability to induce proliferation of BCL I cells. Recently, eosinophil
differentiation factor (EDF) (11, 12) has also been shown to have BCGF-I1
activity and to induce both growth and differentiation of preactivated normal
murine B cells . The recent molecular cloning of cDNA encoding TRF has
confirmed that a single molecule is responsible for both TRF and BCGF-11
activities (13), and most likely for EDF activity too . It has been proposed (13)
that this molecule, recombinant murine TRF(rTRF), be called IL-5 .
EDF has been definedas an activity that stimulates the production of functional
eosinophils from bone marrow in liquid culture system (11, 14) . However, it is
not clear whether this factor is specific for the eosinophil differentiation, or
whether it is analogous to CSFs described for other hemopoietic lineages .
Using clonal cell culture and liquid culture system, we studied the in vitro
effect of IL-5 on murine hemopoietic cells at various stages of differentiation:
bone marrow cells from normal mice, spleen cells of 5-fluorouracil (5-FU)-
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treated mice, blast cells derived from these cells, and mature eosinophils obtained
from mice infected with parasites.
In this study, it was demonstrated that IL-5 was involved in the terminal
differentiation and amplification of eosinophils.
Materials and Methods
Mice. Inbred female BDF, mice, 8-15 wk old, were purchased from the Shizuoka
Experimental Animal Center (Shizuoka, Japan). Mice were administered 5-FU (Adria
Laboratories, Inc., Columbus, OH) through the tail vein at a dosage of 150 mg/kg body
weight. Spleen cells were harvested 4 d later, and we prepared single-cell suspensions
from three to five mice.
Hemopoietic Factors.
￿
For murine rG-CSF we used supernatant of COS cells (COS-sup)
transfected with the cDNA of murine G-CSF cloned by Tsuchiya et al. (2). COS-sup was
kindly provided by Dr. S. Nagata (University of Tokyo). Human native G-CSF was
generously provided by Chugai Pharmaceutical Co. (Tokyo, Japan), and had a sp act of
2.5-5.0 X 10' U/mg protein (15). Murine rGM-CSF was provided by Sumitomo Phar-
maceutical Co . (Osaka, Japan). It had a sp act of 3.7 X 108 U/mg protein. We used
supernatant of COS cells transfected with the cDNA of IL-3 provided by Dr. T. Yokota
(DNAX, Palo Alto, CA) (6). We used rTRF as rIL-5, which synthesized according to the
method described previously (13). Briefly, pSP6K-m tRF23 was cleaved with Sal I to
linearize the plasmid DNA, and mRNAs were synthesized using SP6 RNA polymerase.
The synthesized RNAs were injected into Xenopus oocytes, and their conditioned medium
was collected after incubation for 36 h at 20 °C, and purified using anti-TRF antibody-
coupled affinity column (16). We used medium conditioned by mock-transfected Xenopus
oocytes as the negative control . 1 U of IL-5 was defined as the reciprocal of the dilution
yielding a response that is 50% of the maximal response to the stimulation activity of
BCL, cells.
For the anti-IL-5 antibody, a monoclonal rat IgG, anti-IL-5 antibody was obtained
from a B cell hybridoma, TB13, constructed by fusion between murine myeloma cells
(P3-X63-Ag8.653) and rat spleen cells that had been immunized with HPLC-TRF from
B151 supernatant. Ascitic fluid of mice injected with TB13 was applied to a protein A-
coupled Sepharose CL-4B beads column, and the eluate from the column with 3M
potassium isothiocyanate (pH 8 .0) was used as anti-IL-5 antibody (16, 17).
Clonal Cell Culture.
￿
Cultures of 4 X 104 bone marrow cells per milliliter from normal
mice or 1 .2 X 10' spleen cells per milliliter from 5-FU-treated mice were prepared in 35-
mm non-tissue culture dishes (Falcon Labware, Oxnard, CA) using methylcellulose
medium. 1 ml of 1 .2% methylcellulose (Fisher Scientific Co., Pittsburgh, PA) in a medium
contained 30% FCS, 10 mg BSA (Sigma Chemical Co., St. Louis, MO), and appropriate
amounts of rG-CSF, IL-3, and/or IL-5. The cultures were incubated at 37°C in a
humidified atmosphere of 5% COz in air. The numbers of colonies were scored in the
methylcellulose culture on day 7 or 14. Individual colonies were lifted with a 3-JAI
Eppendorf micropipette in medium containing 30% FCS. The samples were spun in a
centrifuge (Cytospin; Shandon Southern Instruments Inc., Sewickley, PA) and stained
with May-Griinwald-Giemsa.
Replating of Blast Cell Colonies.
￿
Spleen cells from 5-FU-treated mice were cultured in
methylcellulose medium in 35-mm dishes in the presence of 100 U/ml IL-3 or 20 ng/ml
human G-CSF. Blast cell colonies consisting of 50-100 cells were picked up, as described
above, on day 7 of culture and were suspended in a medium containing 30% FCS (18).
After washing twice, ^-200 cells were cultured in methylcellulose medium containing G-
CSF and/or IL-5 . These cultures of replated cells were then incubated at 37°C in 5%
COl in air. After 7 d, each colony formed was lifted, and examined for morphology of
the individual colonies.
Electron Microscopy.
￿
Several colonies in methylcellulose medium containing G-CSF and
IL-5 were fixed in glutaraldehyde and osmium tetroxide, dehydrated, and embedded in
epoxy resin for transmission electron microscopy.YAMAGUCHI ET AL.
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Collection ofEosinophil-rich Peritoneal Exudate Cells.
￿
To obtain eosinophil-rich perito-
neal exudate cells, we modified the methods described by Nawa et al. (19). Briefly, mice
were given an intraperitoneal injection of 200 mg/kg cyclophosphamide (Shionogi Co.,
Osaka, Japan), and 2 d later were infected by oral administration of 500-1,000 Toxocara
canis larvae. 12 d after infection, 1 ml of a 0 .2 mg/ml (protein concentration) Anisakis
extract was injected intraperitoneally, and the peritoneal lavage was collected 48 h later.
T. canis larvae were provided by Dr. S. Kojima (University of Chiba, Chiba, Japan) and
Anisakis extract was provided by Dr. Y. Hayashi and Dr. M. Torisu (University of Kyushu,
Fukuoka, Japan) (20). We used the peritoneal exudate cells as cell suspensions of the
liquid culture.
Liquid Cultures of Murine Peritoneal Exudates Cells.
￿
Cultures were performed using
24-well tissue culture plates (model 25820; Corning Glassworks, Corninf, New York).
Each well contained 2 ml a medium supplemented with 20% FCS, 10 of peritoneal
exudate cells per milliliter, and IL-5 at various concentrations. Cultures were incubated
at 37°C in a fully humidified atmosphere of 5% COz in air. At various times, viable cells
were counted using eosin exclusion, and differential counts of cytospin preparations
stained with May-Grunwald-Giemsa carried out.
Results
Effect of IL-5, G-CSF, GM-CSF, and IL-3 on Colony Formation by Bone Marrow
Cellsfrom Normal Mice. The hemopoietic activities of each CSF and IL-5 were
investigated using the methylcellulose culture method. As shown in Fig. 1 A, an
eosinophil colony was of compact type and consisted of medium-sized cells with
dark hue. However, it was difficult by inverted microscope observations to
identify the lineages of cells in mixed colonies, so individual colonies were lifted
from the dishes and stained with May-Grunwald-Giemsa for the analysis of cell
composition. Fig. 1 B shows a portion of cytospun preparation, revealing that
these cells were eosinophils. Electron microscopic studies confirmed the charac-
teristic crystalloid structure of granules in mature eosinophils (Fig. 2). As shown
in Table I, murine rIL-5 alone was able to support growth of a small number of
colonies of untreated bone marrow cells. All the colonies formed were predom-
inantly eosinophils (86-100%) . These eosinophil colonies began to develop and
increase in size after 5 d of culture. No significant dose-response relationship
between the number of eosinophil colonies and the concentration (2-32 U/ml)
of IL-5 was observed. Maximal number of eosinophil colonies was 3 ± 1 per 2 x
104 normal bone marrow cells at the concentration of 4-32 U/ml. G-CSF
supported growth of only neutrophils and/or macrophage colonies, no eosino-
phils being detected in cultures thus treated. The effects of murine rG-CSF
(dilution of COS-sup, 1 :200) was compared with those of human native G-CSF
(20 ng/ml), but there were no significant differences in their activities or lineage
specificities. Since human G-CSF was highly purified compared with murine rG-
CSF, we used human G-CSF in subsequent experiments.
Murine rGM-CSF supported growth of colonies containing neutrophils, mac-
rophages, and/or a small number of eosinophils. IL-3 supported multilineage
colonies containing neutrophils, macrophages, eosinophils, mast cells, and me-
gakaryocytes. The incidence of colonies containing eosinophils was 23% of the
total.
Addition of IL-5 to cultures containing G-CSF or GM-CSF led to the formation
of colonies containing eosinophils, but did not alter the total number ofcolonies.
In contrast, no significant increase of eosinophil colonies was observed in the46
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FIGURE 1 .
￿
(A) Appearance ofa typical colony containing eosinophils on day 14 of culture in
the presence of rG-CSF and IL-5 . (B) A portion of a May-Grunwald-Giemsa-stained smear of
the colony shownA, revealing eosinophils .
dishes containing IL-3 . The addition of the supernatant of Xenopus oocytes as
negative control of IL-5 had no effect on colony formation . Since GM-CSF and
IL-3 were able to induce by themselves formation of colonies containing eosin-
ophils, we mainly examined the synergistic effects of IL-5 with G-CSF in the
following experiments .
Synergistic Effect of IL-5 on Spleen Cells from 5-FU-treated Mice .
￿
We have
previously reported that treatment of mice with a high dose of 5-FU resulted in
enrichment of primitive hemopoietic progenitors (18), and that rG-CSF was able
to support growth of multilineage colonies containing neutrophils, macrophages,
mast cells, and megakaryocytes, but not eosinophils from spleen cells of 5-FU-
treated mice (21) . Using this system, we first investigated whether IL-5 promotedYAMAGUCHI ET AL .
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FIGURE 2 .
￿
Ultrastructure of a mature eosinophil in culture . The crystalloid structure of the
granules (indicated by the arrows) is characteristics of mature eosinophils . Magnification,
x20,400 .
proliferation and differentiation of hemopoietic progenitor cells. rIL-5 alone did
not support any colony formation at concentrations of 4 and 8 U/ml . On the
other hand, in the presence of rG-CSF, various types of colonies were formed
by these cells . These colonies were larger than those formed by the normal bone
marrow cells described above, indicating that they were derived from the more
primitive hemopoietic cells that had survived the treatment with 5-FU . Table II
shows the IL-5 dose-response relationship for colony formation by spleen cells
from 5-FU-treated mice . G-CSF alone failed to form the colonies containing
eosinophils, but their appearance increased in a dose-dependent manner with
the addition of up to 8 U/ml IL-5 . At this concentration, 24 of 47 colonies
contained eosinophils .
Table III shows the compositions of the various types of colonies formed in
the presence of 20 ng/ml G-CSF and 8 U/ml IL-5 . In mixed colonies containing
eosinophils (Nos . 1-24), the proportion of eosinophils was different in each
colony, ranging from 2 to 96% . ^-60% of these colonies consisted of >40%
eosinophils, clearly demonstrating that IL-5 had amplified the eosinophil popu-
lation . Blast cells were defined as those without any signs of differentiation . On48
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TABLE I
Effect ofIL-5 and Various CSFs (G-CSF, GM-CSF, IL-3) on Colony Formation by Bone
Marrow Cellsfrom Normal Mice
* A total of 4 x 10* bone marrow cells from normal mice per dish were plated and cultured for 7 d. All colonies were lifted and
examined forcell lineages using cytocentrifuge preparations stained with May-Grunwald-Giemsa.
t Colonies contained the majority ofeosinophils: four colonies contained >99% eosinophils, one colony contained 86% eosinophils,
6% neutrophils, and 8% macrophages.
1 The range ofpercentage of eosinophils contained in a colony is shown.
1A All data were analyzed statistically by the x2 test, and significance was set at p < 0.01 .
TABLE II
Dose-Response Relationship for IL-5's Fffects on Colony Formation by Spleen Cellsfrom 5-FU-
treated Mice
II--5 alone
￿
G-CSF
￿
G-CSF
￿
G-CSF
￿
G-CSF
G-CSF
￿
(20 ng/ml)
￿
(20 ng/ml)
￿
(20 ng/ml)
￿
(20 ng/ml)
CSFs
￿
alone
4 U/n,l
￿
8 U/nil
￿
(20 ng/ml)
￿
+ 1L-5
￿
t IL-5
￿
t IL-5
￿
t IL-5
(2 u/mq
￿
(4 u/mq
￿
(s u/mq
￿
(IS u/mq
* A total of 1.2 x 106 spleen cells from 5-FU-treated mice per dish were plated and cultured for 14 d. All colonies were lifted and
examined forcell lineage using cytocentrifuge preparations stained with May-Grunwald-Giemsa.
day 15 of culture, immature colonies (e.g., Nos. 24 and 35) were still observed.
These findings suggest that the development and maturation of individual
colonies was different for each. We found no difference between the proportions
of blast cells in dishes containing G-CSF alone and those containing G-CSF plus
IL-5 (data not shown). Table IV shows the comparative data for colonies formed
either in the presence of G-CSF alone or G-CSF plus IL-5 . Other than those of
the eosinophil lineage, the proportions of cellsof all lineages, such as neutrophils,
macrophages, and mast cells, were not different in cultures containing G-CSF
alone and G-CSF plus IL-5.
As reported in our previous paper (22), GM-CSF was able to support very few
colonies formed by spleen cells from 5-FU-treated mice, indicating that it did
not act on more primitive stem cells.
IL-3 alone induced the development of multilineage colonies containing neu-
trophils, macrophages, mast cells, eosinophils, and megakaryocytes. Colonies
Number ofcolonies not containing eo- 0 0 39* 41 31 23 47
sinophils
Number ofcolonies containing eosino- 0 0 0 3 11 24 13
phils
Number oftotal colonies 0 0 39 44 44 47 60
Percent colonies containing eosinophils 0 0 0 7 26 51 22
CSFs
IL-5
(8 U/ml)
G-CSF
(20 ng/ml)
G-CSF
(8U/ml)
GM-CSF
(100 U/ml)
GM-CSF
+ IL-5
(8 U/ml)
IL-3
(200 U/ml)
IL-3
+ IL-5
(8 U/ml)
Number ofcolonies not containing 0 34* 32 72 60 68 64
eosinophils
Number of colonies containing eo- 5t 0 4 4 16 20 24
sinophils (86-100%)1 (5-93%)' (7-17%)' (1-100%~ (4-90%)' (2-96%)'
Number of total colonies 5 34 36 76 76 88 88
Percent colonies containing eosino- 100 01 11 1 5s 21' 23 27
philsG-CSF
(20 ng/ml)
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TABLE III
Composition ofMultilineage Colonies Formed in the Presence of G-CSF (20 ng/ml) and
IL-5 (8 U/ml)
G-CSF(20 ng/ml)
IL-5 (8 U/ml)
TABLE IV
Numbers ofDifferent Types ofColonies Formed by Spleen Cellsfrom
5-FU-treated Mice in the Presence ofG-CSF Alone or G-CSF
Plus IL-5
m
￿
5(13%)
￿
m + e, m
￿
6(13%)
n, m
￿
24(62%)
￿
n, m +e, n, m
￿
24(51%)
n, mast
￿
2(5%)
￿
n, mast
￿
1 (2%)
n, m, mast
￿
8 (20%)
￿
n, m, mast + e, n, m, mast
￿
14(30%)
n, m, mast, M + e, n, m, mast, M
￿
2(4%)
Total 39(100%)
￿
47(100%)
e, eosinophil; n, neutrophil; m, macrophage; mast, mast cell; M, megakar-
yocyte. Differential counts were carried out on 200 cells.
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All colonies in each dish were lifted and examined for morphology. Differential counts were
performed on 200cells stained with May-Griinwald-Giemsa.
* e, eosinophil;n, neutrophil; m, macrophage; mast, mast cell; M, megakaryocyte;and BI, blast cell.
Colony
number e* n m Mast M BI Colony
number
e n m Mast M BI
1 96 2 2 25 96 2 2
2 92 4 4 26 81 1 10 8
3 91 5 3 1 27 74 11 8 7
4 73 13 12 2 28 73 12 15
5 70 23 7 29 68 5 12 2 13
6 68 15 17 30 62 21 17
7 63 37 31 55 19 22 4
8 62 10 6 1 21 32 54 44 2
9 59 20 21 33 52 7 41
10 55 18 26 1 34 40 46 14
11 50 4 33 13 35 28 4 68
12 49 49 2 36 27 73
13 48 28 20 4 37 24 2 65 9
14 47 20 33 38 17 83
15 40 53 6 1 39 12 88
16 21 45 2 6 26 40 8 91 1
17 15 25 60 41 8 92
18 13 51 36 42 8 81 11
19 11 51 36 2 43 100
20 8 51 21 3 17 44 100
21 7 47 40 6 45 100
22 3 54 15 2 26 46 100
23 2 63 13 22 47 100
24 2 19 1 7850
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TABLE V
Effect ofIL-5, IL-3, and Anti-IL-5 Antibody on Colony Formation by Spleen Cellsfrom
5-FU-treated Mice
G-CSF (20
ng/ml) IL-3 (200
*A total of 1 .2 x 10 6 spleen cells from 5-FU-treated mice per dish were plated and cultured for 14
days . All colonies were lifted andexamined for morphology .
Numbers in parentheses represents percentages of colonies containing eosinophils .
containing eosinophils made up 44% (28 of 64 colonies) of the total number .
Although theaddition of IL-5 to cultures containing IL-3 increased the formation
of colonies containing eosinophils up to 69% (44 of 64 colonies), the proportion
of eosinophils in total constituent cells of each colony was no different, being 2-
26% in a dish containing IL-3 alone and 3-25% in a dish containing IL-3 plus
IL-5 .
Effects ofAnti-IL-5 Antibodies .
￿
Table V shows the effect of anti-IL-5 antibody
in the presence of IL-5 plus G-CSF, or IL-3 on colony formation by spleen cells
from 5-FU-treated mice . By the addition of anti-IL-5 antibody (1 :2,000) to the
culture, formation of eosinophil colonies in the presence of G-CSF (20 ng/ml)
and IL-5 (8 U/ml) was neutralized, whereas their formation was not affected in
cultures containing IL-3 (200 U/ml). The same amount of ascites, used as a
negative control for the antibody, did not have on colony formation .
Development of Eosinophil Colonies from Blast Cells .
￿
By the observation of
spleen cells from 5-FU treated mice, it was demonstrated that IL-5 could support
the proliferation and differentiation of eosinophils in the coexistence of G-CSF .
However, in such cultures, dishes contained 1 .2 X 106 cells/ml . To exclude the
possibility of indirect effects through accessory cells such as macrophages and
lymphocytes, we cultured the enriched population of hemopoietic progenitor
cells at concentrations of 200 cells/ml . When spleen cells from mice pretreated
in vivo with 5-FU were cultured in methylcellulose medium containing rIL-3,
small colonies consisting of blast cells with little sign of differentiation developed
on day 7 of culture . About 10 blast colonies consisting of 20-200 cells could be
identified in a dish that received 106 spleen cells. Blast cell colonies were lifted
on day 7, pooled, washed twice, and replated into secondary methylcellulose
cultures in the presence ofG-CSF with or without IL-5 . In the secondary cultures
containing G-CSF, about 200 blast cells formed 34 small colonies, each consisting
of 50-500 neutrophils and/or macrophages . In the cultures containing G-CSF
CSFs
G-CSF (20
ng/ml)
IL-5 (8 U/ml)
+
IL-5 (8 U/ml)
anti-IL-5
antibody
(1 :2000)
IL-3
(200
U/ml)
U/ml)
anti-IL-5
antibody
(1 :2000)
Number of colonies not containing 19 23 18 20
eosinophils
Number of colonies containing eo- 3(14%) 0 32(64%) 30(60%)
sinophils
Number of total colonies 22 23 50 50TABLE VI
Effect ofIL-5 on Colonies Formed by Secondarily Replated Blast Cells
Supported by IL-3
YAMAGUCHI ET AL.
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Spleen cells from 5-FU-treated mice were incubated in culture medium
containing 100 U/ml IL-3 for7d. On day 7of culture, blast cell colonies
consisting of 50-100 cells were pooled, washed, and replated (^"200
cells/dish) in secondarycultures containing 20 ng/ml G-CSF.
* Colonies consisted of neutrophils andmacrophages only.
Thesetwo colonies were pure eosinophil colonies.
Colonies contained the majority of eosinophils; six colonies were pure
eosinophil colonies, twocolonies consisted of>95% eosinophils, and one
colony consisted of 50% eosinophils.
and IL-5, the same number of blast cells formed 29 small colonies and 9 large
ones, consisting of more than 500 cells each (Table VI). Examination of the
morphology of these colonies revealed that all 29 small colonies consisted of
neutrophilsand macrophages, whereasthe 9 large colonies contained eosinophils,
6 of which were pure eosinophil colonies. On the other hand, in the cultures
containing IL-5 alone, two colonies consisting of >500 cells were formed, both
of which were pure eosinophil colonies.
Similar experiments were done using primary culture of blast cells supported
by G-CSF for 7 d instead of IL-3 . ^-200 cells obtained from blast cell colonies on
day 7 were replated. In secondary dishes containing G-CSF alone, four colonies
were formed, all of which were small and consisted of neutrophils and macro-
phages. In dishes containing G-CSF plus IL-5, five colonies were observed, two
of which were large and consisted of neutrophils, macrophages, and eosinophils,
the proportion of the latter being 81 and 98%. The other colonies were small
and consisted of neutrophils and macrophages. In a dish containing IL-5 alone,
one colony consisting of >1,000 cells was formed, and found to consist of only
eosinophils.
Effects of IL-5 on Mature Eosinophils.
￿
We collected eosinophil-rich peritoneal
exudate cells as described in Materials and Methods. The cells thus obtained
consisted of 52% eosinophils, 42% macrophages, 4% lymphocytes, 1 % neutro-
phils, and 1 % mast cells.
Liquid culture was performed in a medium containing 20% FCS with or
without IL-5 . Fig. 3 shows that IL-5 was able to maintain mature eosinophils up
to 15 d, whereas in its absence the number of eosinophils began to decrease on
day 7 and few viable cells could be detected on day 13. Effects of IL-5 on the
survival of eosinophils were detectable at concentrations ranging from 2 to 16
U/ml . On day 13, 84% of eosinophils were still viable in the presence of 8 U/ml
IL-5, while only 2% survived in its absence.
CSFs IL-5 alone
(8 U/ml)
G-CSFalone
(20 ng/ml)
G-CSF
(20 ng/ml)
+ IL-5
(8 U/ml)
Small colonies (50-500 cells) 0 34* 29*
Large colonies (>500cells) 2t 0 9§
Total 2 34 3852
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FIGURE 3.
￿
In vitrosurvival of mature eosinophils
from eosinophil-rich peritoneal exudate cells in
control and IL-5-containing cultures. At various
times, viable cell numbers were counted using
eosin exclusion, anddifferential counts carried out
by examination of cytocentrifuge preparations
stained with May-Griinwald-Giemsa. Each value is
the mean of data of an experiment performed in
duplicatecultures.
The mechanisms of commitment to eosinophilic differentiation have not been
well defined. Recently, Sanderson et al. (11) reported that supernatants of
alloreactive T cell clones, which contained BCGF II activity, were able to support
the growth of eosinophils in liquid culture. However, a liquid culture system
could notdefine the clonal differentiation from pluripotent stem cellsinto mature
cells. Therefore, a colony assay system was introduced into this study. Based on
analysis of the differentiation potentials of single progenitors, and those ofpaired
daughter cells (23, 24), it was proposed that the feature of differentiation and
proliferation of hemopoietic progenitor cells is a stochastic process, indicating
that each colony was very heterogenous in lineage expression. Thus, in situ
identification or classification of colony type was insufficient to analyze hemo-
poietic differentiation. In this study, we lifted up all the colonies grown in dishes
and examined the cell lineages by staining of cytospun preparations.
In the present study, we found that purified IL-5 alone couldact on untreated
bone marrow cells to support exclusively eosinophil colony formation. However,
it did not support such colony formation by spleen cells from 5-FU-treated mice,
in which only primitive stem cells had survived. Taking our previous findings
into consideration (18, 21), we concluded that IL-3 and G-CSF were able to
support the colony formation by spleen cells from 5-FU-treated mice, whereas
GM-CSF, erythropoietin, and IL-5 were unable to act on such primitive hemo-
poietic cells. It was suggested that IL-5 itself did not influence the differentiation
of lineages other than the eosinophil, as shown by the analysis of the cell
composition of colonies formed in the presence of G-CSF with or without IL-5.
The eosinophilopoietic activity of IL-5 was neutralized by anti-IL-5 antibody,
but that of IL-3 was not. This suggests that at least two different pathways of
eosinophil differentiation supported by IL-5 and by IL-3 may exist.
To exclude the possibility of interactions between cells in the same dish, we
plated small numbers of enriched hemopoietic progenitors obtained from pri-
mary blast cell colonies that had been supported by IL-3 or G-CSF. A few
eosinophil colonies were formed in the presence of IL-5 alone. Only small-sized
neutrophil/macrophage colonies were formed in the presence of G-CSF alone.
Addition of IL-5 to G-CSF-containing cultures induced formation of eosinophil
colonies. These findings indicate that IL-5 specifically promoted terminal differ-
entiation and amplification of the eosinophils. In this respect, IL-5 seems to
resemble erythropoietin, which facilitates the terminal differentiation and am-Differentiation stage
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plif)cation of erythroid cells (25). Furthermore, when the proportion of eosino-
phils in colonies formed by spleen cells from 5-FU-treated mice was compared
with their proportion in colonies formed by blast cells, the former were found
to show a wide range (2-96%), while the latter showed a high eosinophil
percentage (50-100%) in all colonies. These observations indicated that differ-
entiation along the eosinophil pathway was restricted from pluripotent stem cells
to monopotent progenitors. These data clearly showed that IL-5 amplified
eosinophil numbers, whereas their differentiation potential was supported by G-
CSF. We have to clarify whether or not G-CSF induces the expression of IL-5
receptors, and the in vivo significance of these synergistic interactions of hemo-
poietic cells. We summarized these data in Fig. 4. Blast cells induced by IL-3 or
G-CSF from spleen cells of 5-FU-treated mice appear to be in the same differ-
entiation stage as the majority of untreated bone marrow cells.
In our preliminary studies, murine IL-5 alone was able to support the eosino-
phil colony formation by human bone marrow cells as well as murine cells. It has
been reported that the nucleotide and amino acid sequence homologies of the
coding region of human and murine IL-5 are 77 and 70% (26), respectively.
This human eosinophilopoietic activity of IL-5 seems to be similar to the so-
called Eo-CSF reported by Metcalf et al . (27). IL-5 alone maintained mature
eosinophils in liquid culture system. This effect was also lineage specific. This
result is consistent with that reported by Begley et al. (14) in the human eosinophil
culture system. These data suggested that mature eosinophils might have IL-5
receptors. To exclude the possibility of some influence by macrophages in the
peritoneal exudates, we are now preparing highly enriched eosinophil fractions
by Percoll gradient centrifugation.
In conclusion, IL-5 specifically facilitated the terminal differentiation and
amplification of eosinophils. This mechanism of eosinophilopoiesis may be re-
sponsible for the urgent mobilization of eosinophils during helminthic infections
and allergic responses.
Summary
Using a clonal culture system, we investigated the hemopoietic effects of
purified recombinant IL-5 obtained from conditioned media of transfected
Xenopus oocytes. IL-5 alone acted on untreated bone marrow cells and supported
the formation of a small number of colonies, all of which were predominantly
eosinophilic. However, it did not support colony formation by spleen cells from54
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5-FU-treated mice, in which only primitive stem cells had survived, while IL-3
and G-CSF did . Eosinophil-containing colonies were formed from these cells in
the presence of IL-5 and G-CSF together. In contrast, G-CSF alone did not
support any eosinophil colonies. The eosinophilopoietic effect of IL-5 was dose-
dependent, and was neutralized specifically by anti-IL-5 antibody.
To exclude the possibility of interactions with accessory cells in the same
culture dish, we replated a small number (200 cells/dish) ofenriched hemopoietic
progenitors, obtained from blast cell colonies, which were formed by cultivation
of spleen cells from 5-FU-treated mice in the presence of IL-3 or G-CSF. From
these replated blast cells, eosinophil colonies were induced in dishes containing
IL-5 but not in those containing G-CSF alone.
From these findings, it was concluded that IL-5 did not act on primitive
hemopoietic cells, but on blast cells induced by IL-3 or G-CSF. IL-5 specifically
facilitated the terminal differentiation and proliferation of eosinophils. In this
respect, the role of IL-5 in eosinophilopoiesis seems to be analogous to erythro-
poietin, which promotes the terminal differentiation and amplification of eryth-
roid cells.
Moreover, IL-5 maintained the viability of mature eosinophils obtained from
peritoneal exudate cells of the mice infected with parasites, indicating mature
functional eosinophils carried IL-5 receptors.
The synergistic effects of IL-5 and colony-stimulating factors on the expansion
of eosinophils is supposed to contribute to the urgent mobilization of eosinophils
at the time of helminthic infections and allergic responses.
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for skillful technical assistance.
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